Discuss This Drug

Respiratory Syncytial Virus Vaccine

CHEBI:CHEBI_752381

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20251231
route
INTRAMUSCULAR
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
marketing_start_date
20240531
package_marketing_start_date
20240531
product_type
VACCINE
marketing_category
BLA
labeler_name
Moderna US, INC.
active_ingredient_strength
.06 mg/.5mL
generic_name
Respiratory Syncytial Virus Vaccine
brand_name
Abrysvo
brand_name_base
Abrysvo
product_ndc
0069-2465
application_number
BLA125769
spl_id
18e58ae7-b9a7-4011-ae38-cdcee690ca2d
active_ingredient_name
RECOMBINANT STABILIZED RSV B PREFUSION F ANTIGEN
package_ndc
0069-2465-10
package_description
10 VIAL in 1 CARTON (0069-2465-10) / .5 mL in 1 VIAL (0069-2465-19)
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class